![Opening of a new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research](https://thenativeantigencompany.com/wp-content/uploads/2022/10/DSC08301-1080x675.jpg)
![Opening of a new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research](https://thenativeantigencompany.com/wp-content/uploads/2022/10/DSC08301-1080x675.jpg)
![The Native Antigen Company (Part of LGC Clinical Diagnostics) has moved to a new state-of-the-art site in Oxford, delivering critical diagnostics solutions and research.](https://thenativeantigencompany.com/wp-content/uploads/2022/10/Opening-ceremony-TNAC-1080x675.jpg)
The Native Antigen Company (Part of LGC Clinical Diagnostics) has moved to a new state-of-the-art site in Oxford, delivering critical diagnostics solutions and research.
Left to Right: Euan O’Sullivan (President and Chief Executive Officer LGC Group), Dame Sarah Gilbert DBE , Mark Dearden (Managing Director, LGC Biosearch Technologies) Teresa Lambe OBE, Nicholas Roesen, (COO The Native Antigen Company), Bharathi Anekella...![Monkeypox; 3 months on](https://thenativeantigencompany.com/wp-content/uploads/2022/08/Pox-Virus-01-1000x675.jpg)